QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 alpha-teknova-affirms-fy2025-sales-guidance-of-39000m-42000m-vs-40235m-est

Reiterates 2025 OutlookTeknova reiterates its fiscal 2025 outlook for revenue and free cash outflow. The Company continues to a...

 alpha-teknova-affirms-fy2025-sales-guidance-of-3900m-4200m-vs-4055m-est

Alpha Teknova (NASDAQ:TKNO) affirms FY2025 sales outlook from $39.00 million-$42.00 million to $39.00 million-$42.00 million vs...

 alpha-teknova-q1-eps-009-beats-012-estimate-sales-979m-beat-937m-estimate

Alpha Teknova (NASDAQ:TKNO) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.12)...

 reported-earlier-teknova-and-pluristyx-announce-strategic-collaboration-to-commercialize-plurifreeze-streamlining-cell-therapy-development

Alpha Teknova, Inc. and Pluristyx, Inc., today announced that the companies are collaborating to produce and commercialize Plur...

 alpha-teknova-sees-fy2025-sales-39000m-42000m-vs-4170m-est

Alpha Teknova (NASDAQ:TKNO) sees FY2025 sales of $39.000 million-$42.000 million vs $41.70 million analyst estimate.

 alpha-teknova-q4-eps-011-beats-012-estimate-sales-927m-beat-872m-estimate

Alpha Teknova (NASDAQ:TKNO) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12)...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION